Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03423719
Other study ID # FITCT2015
Secondary ID
Status Completed
Phase N/A
First received January 30, 2018
Last updated February 5, 2018
Start date April 2015
Est. completion date September 2017

Study information

Verified date January 2018
Source Fytexia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effects of a 16-week supplementation with a polyphenol-rich extract, Fiit-ns®, on improvement of health-related quality of life (HR-QOL) of overweight and obese volunteers, as compared to placebo. Previous beneficial results from a pilot study showed that the supplementation may improve quality of life as well as body composition. Based on such results, this pivotal study is statistically powered to detect significant differences in HR-QOL assessed with the Short Form-36 Health survey (SF-36) between baseline (Week 1, W1) and end of the supplementation period (Week 16, W16).


Recruitment information / eligibility

Status Completed
Enrollment 92
Est. completion date September 2017
Est. primary completion date September 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 55 Years
Eligibility Inclusion Criteria:

- 25 kg/m2 = Body Mass Index (BMI) = 40 kg/m2

- 25-55 years old

Exclusion Criteria:

- Metabolic and/or chronic disease (diabetes, dyslipidemia, thyroiditis, inflammatory disease, immunological disease, asthma, anxiety, depression)

- Allergy to one of the ingredients of the supplement

- Current involvement of involvement within the 6 previous months in a chronic supplement program, chronic treatment program, weight loss program

- Smoking cessation

- High alcohol consumption

- Pregnancy

- Breastfeeding

- Menopausal women

- Involvement in physical activity more than twice a week

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Fiit-ns®
Fiit-ns® is a blend of polyphenol-rich extracts from grapefruit, grape, green tea, guarana and black carrot. It also provides Vitamin B3. Daily dosage is 900 mg in two 450 mg-capsules for 16 weeks.
Placebo
Placebo product is 100% maltodextrin. Daily dosage is 900 mg in two 450 mg-capsules of identical appearance than the supplement capsule for 16 weeks.

Locations

Country Name City State
Spain UCAM (Universidad Catolica San Antonio de Murcia) Murcia

Sponsors (1)

Lead Sponsor Collaborator
Fytexia

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in health-related quality of life as assessed by the SF-36 Health Survey Baseline (Week 1) and end of the supplementation period (Week 16)
Secondary Change in body weight Change in body weight is measured with calibrated weighing scales Baseline (Week 1) and end of the supplementation period (Week 16)
Secondary Change in waist circumference Change is waist circumference is measured with a non-stretchable tape and used to calculate change in Index of Central Obesity (ICO) Baseline (Week 1) and end of the supplementation period (Week 16)
Secondary Change in total body fat mass Change in total body fat mass is measured with Dual-Energy X-ray Absorptiometry (DXA) scan Baseline (Week 1) and end of the supplementation period (Week 16)
Secondary Change in trunk fat mass Change in trunk fat mass is measured with Dual-Energy X-ray Absorptiometry (DXA) scan Baseline (Week 1) and end of the supplementation period (Week 16 )
Secondary Change in physical activity level Physical activity is assessed with International Physical Activity Questionnaire (IPAQ) IPAQ consists in 27 items that cover 4 different domains of physical activity (working, transportation, housework and gardening & leisure-time) in terms of time spent during the 7 previous days.
Total score is the sum of the 4 domains and results are presented as an estimation of energy expenditure in metabolic equivalent-minutes per week (Met-min/week).
Baseline (Week 1) and end of the supplementation period (Week 16)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03602001 - Attentive Eating for Weight Loss N/A
Recruiting NCT06269159 - The Power of 24-hour: Co-designing Intervention Components
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT02996864 - Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II N/A
Terminated NCT03914066 - A Group-based Treatment of Overweight and Obesity in Primary Care N/A
Completed NCT04647149 - Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity N/A
Completed NCT03685656 - Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers N/A
Completed NCT05051579 - A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities Phase 2
Completed NCT04611477 - Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals N/A
Active, not recruiting NCT05330247 - Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study N/A
Completed NCT03599115 - Effects of Inhibitory Control Training in Eating Behaviors N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Recruiting NCT05938894 - Train Your Brain - Executive Function N/A
Recruiting NCT05987306 - A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss N/A
Completed NCT03792685 - Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention N/A
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Completed NCT04520256 - Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy Phase 2/Phase 3
Completed NCT04979234 - A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome N/A